Chemical Compound

Casuarictin

CAS Registry Number 79786-00-8
Casuarictin chemical structure
Primary Record

Casuarictin

In stock
8,396 g
Purity
99.7 %
CAS
79786-00-8

Compound Identifiers & Properties

CAS
79786-00-8
PubChem CID
73644
SMILES
C1[C@@H]2[C@H]([C@H]3[C@H]([C@@H](O2)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C(=C5C6=C(C(=C(C=C6C(=O)O3)O)O)O)O)O)O)OC(=O)C7=CC(=C(C(=C7C8=C(C(=C(C=C8C(=O)O1)O)O)O)O)O)O
Canonical SMILES
O=C(O[C@@H]1O[C@@H]2COC(=O)c3cc(O)c(O)c(O)c3-c3c(cc(O)c(O)c3O)C(=O)O[C@H]2[C@@H]2OC(=O)c3cc(O)c(O)c(O)c3-c3c(cc(O)c(O)c3O)C(=O)O[C@@H]12)c1cc(O)c(O)c(O)c1

Names & Synonyms

  • Casuarictin
  • Sanguiin H 11
  • casuaricitin
  • cuspinin
  • Sanguiin H-11
  • Galloyl pedunculagin
  • 1-O-Galloylpedunculagin
  • 1(beta)-O-Galloylpedunculagin
  • RefChem:918123
  • 1beta-O-Galloylpedunculagin
  • CHEMBL446979
  • DTXSID401000730
  • 79786-00-8
  • AC1L2K81
  • AC1Q6P15
  • CHEBI:3461
  • 1(.beta.)-O-Galloylpedunculagin
  • alpha-Glucosidase inhibitor CB-3
  • SWRFKGRMQVLMKA-JIZJWZDPSA-N
  • casuarictin, (beta-D-Glc)-isomer
  • DTXCID701427690
  • KST-1A0011
  • CID73644
  • AR-1A0352
  • BDBM50250990
  • C41H28O26
  • CID:73644
  • C41-H28-O26
  • casuarictin, (alpha-D-Glc)-stereoisomer
  • PD179049
  • SID:475720859
  • J294.472C
  • 96292-46-5
  • C10212
  • casuarictin, beta-D-Glc)-(2(R),3(R)-isomer
  • C073064
  • [(1R,2S,19R,20S,22R)-7,8,9,12,13,14,28,29,30,33,34,35-dodecahydroxy-4,17,25,38-tetraoxo-3,18,21,24,39-pentaoxaheptacyclo[20.17.0.02,19.05,10.011,16.026,31.032,37]nonatriaconta-5,7,9,11,13,15,26,28,30,32,34,36-dodecaen-20-yl] 3,4,5-trihydroxybenzoate
  • (10ar,11s,12ar,25ar,25bs)-2,3,4,5,6,7,17,18,19,20,21,22-dodecahydroxy-9,15,24,27-tetraoxo-9,10a,11,12a,13,15,24,25a,25b,27-decahydrodibenzo[g,i]dibenzo[6',7':8',9'][1,4]dioxecino[2',3':4,5]pyrano[3,2-b][1,5]dioxacycloundecin-11-yl 3,4,5-trihydroxybenzoate
  • [dodecahydroxy(tetraoxo)[?]yl] 3,4,5-trihydroxybenzoate
  • (6aR,7S,8aR,21aR,21bS)-1,2,3,13,14,15,16,17,18,25,26,27-dodecahydroxy-5,11,20,23-tetraoxo-5,6a,7,8a,9,11,20,21a,21b,23-decahydrodibenzo[g,i]dibenzo[6',7':8',9'][1,4]dioxecino[2',3':4,5]pyrano[3,2-b][1,5]dioxacycloundecin-7-yl 3,4,5-trihydroxybenzoate
  • ((1R,2S,19R,20S,22R)-7,8,9,12,13,14,28,29,30,33,34,35-dodecahydroxy-4,17,25,38-tetraoxo-3,18,21,24,39-pentaoxaheptacyclo(20.17.0.02,19.05,10.011,16.026,31.032,37)nonatriaconta-5,7,9,11,13,15,26,28,30,32,34,36-dodecaen-20-yl) 3,4,5-trihydroxybenzoate
  • (1R)-1-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl)oxycyclopent-2-ene-1-carbonitrile
  • (1R,2S,19R,20S,22R)-7,8,9,12,13,14,28,29,30,33,34,35-dodecahydroxy-4,17,25,38-tetraoxo-3,18,21,24,39-pentaoxaheptacyclo[20.17.0.02,19.05,10.011,16.026,31.032,37]nonatriaconta-5,7,9,11,13,15,26,28,30,32,34,36-dodecaen-20-yl 3,4,5-trihydroxybenzoate
  • (3,4,5-Trihydroxybenzoyl)2-O,3-O:4-O,6-O-bis[(4,4 ,5,5 ,6,6 -hexahydroxy-1,1 -biphenyl-2,2 -diyl)dicarbonyl]-beta-D-glucopyranoside
  • .beta.-D-Glucopyranose, cyclic 2,3:4,6-bis[(1S)-4,4',5,5',6,6'-hexahydroxy[1,1'-biphenyl]-2,2'-dicarboxylate] 1-(3,4,5-trihydroxybenzoate)
  • 2-O,3-O:4-O,6-O-Bis(4,4 ,5,5 ,6,6 -hexahydroxy-1,1 -biphenyl-2,2 -diyldicarbonyl)-1-O-galloyl-beta-D-glucopyranose
  • 2-O,3-O:4-O,6-O-Bis[(4,4 ,5,5 ,6,6 -hexahydroxy-1,1 -biphenyl-2,2 -diyl)biscarbonyl]-beta-D-glucopyranose 1-(3,4,5-trihydroxybenzoate)
  • 3,4,5-Trihydroxybenzoyl 2-O,3-O:4-O,6-O-bis[(4,4 ,5,5 ,6,6 -hexahydroxybiphenyl-2,2 -diyl)biscarbonyl]-beta-D-glucopyranoside
  • 3,4,5-Trihydroxybenzoyl 2-O,3-O:4-O,6-O-bis[2,2 ,3,3 ,4,4 -hexahydroxy[1,1 -biphenyl]-6,6 -diylbis(carbonyl)]-beta-D-glucopyranoside
  • beta-D-Glucopyranose, cyclic 2,3:4,6-bis(4,4',5,5',6,6'-hexahydroxy(1,1'-biphenyl)-2,2'-dicarboxylate) 1-(3,4,5-trihydroxybenzoate), (2(S),4(S))-